Seeking Alpha on MSN7h
Henry Schein extends gain on report of activist stake, push for board changes
Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...
Analyst Ratings For Henry Schein
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...
Henry Schein: Buy Rating Affirmed Amid Strong Profitability and Strategic Cost Management
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...
Nasdaq12d
Analyst Ratings For Henry Schein
Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below summarizes their recent ratings, showcasing the ...